Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis
NCT00004368 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2005-06-24
Summary
OBJECTIVES:
I. Investigate the efficacy and safety of colchicine therapy in improving hepatic function and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis.
Conditions
- Cirrhosis
- Liver Cirrhosis
Interventions
- DRUG
-
colchicine
Sponsors & Collaborators
-
Children's Hospital Colorado
collaborator OTHER -
National Center for Research Resources (NCRR)
lead NIH
Principal Investigators
-
Ronald J. Sokol · Children's Hospital Colorado
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 0 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1990-05-31
More Related Trials
-
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
NCT04634643 ·Status: RECRUITING
-
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
NCT01529268 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of To Be Marketed (TBM) Cholic Acid Capsules Used to Treat Children With Inborn Errors of Bile Acid Synthesis
NCT01115582 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
NCT01088607 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of LUM001 in the Reduction of Pruritus in Alagille Syndrome
NCT02057692 ·Status: COMPLETED ·Phase: PHASE2
-
Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid Synthesis
NCT01438411 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis
NCT00004441 ·Status: COMPLETED ·Phase: NA
-
Study of Lactulose in Children With Chronic Liver Disease
NCT00811434 ·Status: TERMINATED ·Phase: PHASE2
-
Nutritional Assessment Tool and Nutritional Intervention in Childhood Chronic Liver Disease
NCT02715973 ·Status: COMPLETED ·Phase: NA
-
Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease
NCT00004315 ·Status: UNKNOWN ·Phase: PHASE2
-
Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition
NCT00004697 ·Status: COMPLETED ·Phase: NA
-
Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants
NCT00004410 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)
NCT00677521 ·Status: TERMINATED ·Phase: PHASE2
-
Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis
NCT03312140 ·Status: COMPLETED ·Phase: NA
-
Ursodiol for Treating Parenteral Nutrition Associated Cholestasis in Neonates
NCT00846963 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Alagille Syndrome
NCT01903460 ·Status: COMPLETED ·Phase: PHASE2
-
Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease
NCT05582447 ·Status: ACTIVE_NOT_RECRUITING
-
Effects of Tomato Products in Children With NAFLD
NCT03463967 ·Status: UNKNOWN ·Phase: NA
-
SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease
NCT03867487 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency
NCT00006061 ·Status: COMPLETED ·Phase: NA
-
Fatty Liver Disease in Obese Children
NCT02117700 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease
NCT05922332 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease.
NCT05093218 ·Status: UNKNOWN ·Phase: NA
-
Study of Bile Acids in Patients With Peroxisomal Disorders
NCT00004442 ·Status: TERMINATED ·Phase: NA
-
Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients
NCT05279586 ·Status: UNKNOWN ·Phase: EARLY_PHASE1